Microencapsulated API (Coated Granules, Pellets & MUPS)

  • Microencapsulated API (Coated Granules, Pellets & MUPS) 1
  • Microencapsulated API (Coated Granules, Pellets & MUPS) 2
  • Microencapsulated API (Coated Granules, Pellets & MUPS) 3
Product Description

Acetaminophen Taste Masked Coated Granules; Acetylsalicylic Acid Enteric Coated Granules / Pellets; 
Ascorbic Acid Coated Granules; 
Azithromycin Taste Masked Granules; 
Ciprofloxacin Taste Masked Coated Granules; 
Citric Acid Coated Granules;
Clarithromycin Taste Masked Coated Granules;
Dexlansoprazole Dual Delayed Release Pellets;
Duloxetine Delayed Release Pellets;
Diclofenac Sodium EC/MR/SR Pellets;
Doxycycline Delayed Release Pellets;
Esomeprazole Delayed Release Pellets / MUPS;
Itraconazole Immediate Release Pellets;
Ibuprofen Taste Masked Coated Granules;
Lansoprazole Delayed Release Pellets;
Mebeverine Taste Masked Coated Granules & SR Pellets;
Orlistat Coated Pellets;
Secnidazole Taste Masked Coated Granules;
Sodium Bicarbonate Coated Granules;
Tamsulosin Sustained Release Pellets;
Vitamin B1 (Thiamine) Coated Granules;
Vitamin B2 (Riboflavin) Coated Granules;
Vitamin B6 (Pyridoxine) Coated Granules;
Vitamin B12 (Cyanocobalamin) Coated Granules

Read more Show less

Nabiqasim Pharma Group

  • Country/Region:
    Pakistan
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Price; Product Performance; Prompt Delivery; Quality Service; Small Orders Accepted; We transform challenging APIs through advanced
    microencapsulation technology, delivering taste
    masking, controlled release, enteric and moisture
    protection, and directly compressible pellets &
    granules - enhancing product performance and
    improving patient compliance
  • Measured In
    kilogram
More specifications Fewer specifications

Nabiqasim Pharma Group

  • Country/Region:
    Pakistan
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile

More Products from Nabiqasim Pharma Group (4)

  • Cardiovascular

    Product Cardiovascular

    Nabiqasim offers a wide range of Cardiovascular products in combination and single ingredient including APIXABAN; RIVIROXABAN; SACUBITRIL+VALSARTAN; ROSUVASTATIN+EZETIMIBE and many others. 
  • Contract Manufacturing Operations (CMO)

    Product Contract Manufacturing Operations (CMO)

    Nabiqasim Pharma Group offers integrated Contract Development & Manufacturing Operations (CDMO) for pharmaceutical companies seeking a reliable partner for Branded Generic Formulations. Our capabilities include Prostaglandins, Laxatives/Enemas, Lyophilized Infusions, Tablets & Capsules, Liquids &am...
  • DC GRANULES

    Product DC GRANULES

    Acetaminophen DC Granules; Amlodipine + Olmesartan Medoxomil DC Granules; Amlodipine + Perindopril DC Granules; Amlodipine + Telmisartan DC Granules; Amlodipine + Valsartan DC Granules; Amlodipine + Valsartan + Hydrochlorothiazide DC Granules; Atorvastatin DC Granules; Azithromycin DC Granules; Carvedilol ...
  • Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED)

    Product Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED)

    Lyophilized vials

Nabiqasim Pharma Group resources (1)

  • PIC/S and ANVISA Approval

    News PIC/S and ANVISA Approval

    Nabiqasim Pharma proudly announces the successful accreditation of its Injectable & Lyophilized Section by ANVISA and Hormonal Solid Dosage Manufacturing Section by PIC/S. 
    10 Oct 2025